The objective of this order is to obtain the services of an independent consulting firm to assess current FDA alternative methods activities across relevant centers/offices by: ? Creating an FDA…
Ended Awarded Last action
- Contract number
- 75F40122F19014
- Awardee
-
Booz Allen Hamilton Inc. UEI JCBMLGPE6Z71 Part of Booz Allen Hamilton Holding Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $895,272
Award facts
- Contract value 100% obligated
- $895,272.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- North Bethesda, MD 20852, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$4,551 | |
| Original award | $899,823 |
About this award
This federal contract award is for the Food and Drug Administration (FDA) to obtain the services of an independent consulting firm to assess current FDA alternative methods activities across relevant centers and offices. The contract, which is a Blanket Purchase Agreement (BPA) call under the Multiple Award Schedule (MAS) contract, was awarded to Booz Allen Hamilton Inc. for a ceiling value of $895,272.20. The contract has a period of performance ending on September 29, 2023. Booz Allen Hamilton Inc. is a leading provider of management, technology, and engineering services to the U.S. government, specializing in defense, intelligence, and civil markets. The company has an extensive history of providing a wide range of goods and services through prime and subcontract awards across various federal agencies, including the Department of Defense, Department of Veterans Affairs, and Centers for Disease Control and Prevention.
Description
The objective of this order is to obtain the services of an independent consulting firm to assess current FDA alternative methods activities across relevant centers/offices by: ? Creating an FDA inventory across FDA centers and offices of: O ALT
Quick answers
Who was awarded contract 75F40122F19014?
75F40122F19014 was awarded to Booz Allen Hamilton Inc. by Food and Drug Administration (Department of Health and Human Services) on September 28, 2022.
How much is contract 75F40122F19014 worth?
The government has obligated $895,272 on 75F40122F19014.
Is contract 75F40122F19014 an order under another contract?
Yes. 75F40122F19014 is a BPA call under GS00F008DA-75F40122A00008, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40122F19014 competed?
The extent of competition for 75F40122F19014 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award